Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer.

PURPOSEMetastatic breast cancer (MBC) has a heterogeneous clinical course. We sought to develop a prognostic model for overall survival (OS) that incorporated contemporary tumor and clinical factor...